UBS Group
ANVS icon

UBS Group’s Annovis Bio ANVS Stock Holding History

UBS Group’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48K Sell
21,538
-9,105
-30% -$25K ﹤0.01% 7394
2025
Q4 		$106K Buy
30,643
+30,010
+4,741% +$90.2K ﹤0.01% 6883
2025
Q3 		$1.31K Sell
633
-25,684
-98% -$64.2K ﹤0.01% 9380
2025
Q2 		$57.1K Sell
26,317
-134,559
-84% -$266K ﹤0.01% 7671
2025
Q1 		$241K Buy
160,876
+112,140
+230% +$343K ﹤0.01% 6416
2024
Q4 		$245K Buy
48,736
+46,889
+2,539% +$339K ﹤0.01% 6328
2024
Q3 		$14.9K Sell
1,847
-11,143
-86% -$104K ﹤0.01% 7529
2024
Q2 		$74.8K Buy
12,990
+12,390
+2,065% +$100K ﹤0.01% 6381
2024
Q1 		$7.14K Hold
600
– – ﹤0.01% 7405
2023
Q4 		$11.2K Buy
600
+500
+500% +$4.43K ﹤0.01% 7401
2023
Q3 		$949 Hold
100
– – ﹤0.01% 8208
2023
Q2 		$1.43K Buy
+100
New +$1.42K ﹤0.01% 7924
2022
Q3 		– Sell
-414
Closed -$5K – 10296
2022
Q2 		$5K Buy
+414
New +$4.53K ﹤0.01% 8843
2022
Q1 		– Sell
-2,481
Closed -$44K – 10200
2021
Q4 		$44K Buy
2,481
+2,088
+531% +$53.8K ﹤0.01% 7026
2021
Q3 		$12K Sell
393
-775
-66% -$44.6K ﹤0.01% 7742
2021
Q2 		$100K Buy
+1,168
New +$54K ﹤0.01% 5875

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

UBS Group's ANVS Position: Q1 2026 in Review

UBS Group reduced its Annovis Bio (ANVS) stake by 30% in Q1 2026, selling an estimated $25K and leaving 21,538 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #7394.

UBS Group first reported a position in ANVS in Q2 2021 and has held it in 16 quarters since. The position peaked at $245K in Q4 2024. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • UBS Group held 21,538 shares of Annovis Bio worth $48K as of Q1 2026.
  • UBS Group sold 9,105 Annovis Bio shares in Q1 2026, an estimated $25K.
  • Annovis Bio made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7394 holding.
  • UBS Group first reported a position in Annovis Bio in Q2 2021 and has held it in 16 quarters since.
  • UBS Group's Annovis Bio position peaked at $245K in Q4 2024.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.